Xenon Pharmaceuticals (XENE) Q2 2026 Earnings

7MayConfirmed
Q2 2025
Q3 2025
Q4 2025
Q2 2026
-1.18
-1.06
-0.95
-0.83

Details

Expected EPS
-1.179498
Actual EPS
-1.17
Surprise EPS
0.01
Surprise Percent
+0.81%

Description

Xenon Pharmaceuticals (XENE) has reported earnings of -1.17 per share for Q2 2026.

0 Comments

Share your thoughts